Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation

Cited by (960)

Items 301–400 of 960

1. Comparison of the effects of bupropion and nicotine on locomotor activation and dopamine release in vivo
   Nimish Sidhpura, Peter H. Redfern, Helen L. Rowley, David J. Heal, Susan Wonnacott · 2007 · Biochemical Pharmacology
2. Effects of 21 days of varenicline versus placebo on smoking behaviors and urges among non-treatment seeking smokers
   Rebecca L. Ashare, Kathy Z. Tang, A Clementina Mesaros, Ian A. Blair, Frank T. Leone, Andrew A. Strasser · 2012 · Journal of Psychopharmacology
3. Current Insights into the Mechanisms and Development of Treatments for Heavy-Drinking Cigarette Smokers
   Daniel J. O. Roche, Lara A. Ray, Megan M. Yardley, Andrea C. King · 2016 · Current Addiction Reports
4. Varenicline ameliorates ethanol-induced deficits in learning in C57BL/6 mice
   Danielle Gulick, Thomas J. Gould · 2008 · Neurobiology of Learning and Memory
5. Varenicline and neuronal nicotinic acetylcholine receptors: A new approach to the treatment of co‐occurring alcohol and nicotine addiction?
   Roberto Nocente, Mario Vitali, Giuseppe Balducci, Domenico Enea, Henry R. Kranzler, Mauro Ceccanti · 2013 · American Journal on Addictions
6. Phase II Crossover Trial of Varenicline in Mild-to-Moderate Alzheimer's Disease
   Seong Yoon Kim, Seong Hye Choi, Hans Rollema, Elias M. Schwam, Tom McRae, Sarah Dubrava, Janice Jacobsen · 2013 · Dementia and Geriatric Cognitive Disorders
7. Autism - A Neurodevelopmental Journey from Genes to Behaviour
   Valsamma Eapen · 2011 · InTech eBooks
8. CC 4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation
   Mariaelvina Sala, Daniela Braida, Luca Pucci, Irene Manfredi, Michael J. Marks, Charles R. Wageman, Sharon R. Grady, Barbara Loi, Sergio Fucile, Francesca Fasoli et al. · 2012 · British Journal of Pharmacology
9. Varenicline and cytisine: two nicotinic acetylcholine receptor ligands reduce ethanol intake in University of Chile bibulous rats
   Ramón Sotomayor‐Zárate, Katia Gysling, Usoa E. Busto, Bruce K. Cassels, Lutske Tampier, Marı́a Elena Quintanilla · 2013 · Psychopharmacology
10. Varenicline for smoking cessation: A review of the literature
    Kirandeep Kaur, Sandeep Kaushal, Sarvesh Chander Chopra · 2009 · Current Therapeutic Research
11. Varenicline: New treatment with efficacy in smoking cessation
    Victor I. Reus, Ronald Scott Obach, Jotham W. Coe, Hélène M. Faessel, Hans Rollema, Eric J. Watsky, Karen R. Reeves · 2007 · Drugs of today
12. Differential α4(+)/(−)β2 Agonist-binding Site Contributions to α4β2 Nicotinic Acetylcholine Receptor Function within and between Isoforms
    Linda M. Lucero, Maegan M. Weltzin, Jason Brek Eaton, John F. Cooper, Jon Martin Lindstrom, Ronald J. Lukas, Paul Whiteaker · 2015 · Journal of Biological Chemistry
13. Insertion Reactions on Carbopalladated Benzyne: From Eight- to Nine- and Ten-Membered Palladacycles. Applications to the Synthesis of N-Heterocycles
    Marı́a-José Oliva-Madrid, José-Antonio Garcı́a-López, Isabel Saura‐Llamas, Delia Karina Maya Bautista, José Vicente · 2014 · Organometallics
14. Does Smoking Affect OSA? What about Smoking Cessation?
    Athanasia Pataka, Serafeim‐Chrysovalantis Kotoulas, George Kalamaras, Asterios Tzinas, Ioanna Grigoriou, Nectaria Kasnaki, Paraskevi Argyropoulou · 2022 · Journal of Clinical Medicine
15. Cost-Utility Analysis of Varenicline, an Oral Smoking-Cessation Drug, in Japan
    Ataru Igarashi, Hiroki Takuma, Takashi Fukuda, Kiichiro Tsutani · 2009 · PharmacoEconomics
16. Neuropsychiatric Adverse Events of Varenicline: A Systematic Review of Published Reports
    Ahmed, Amir I.A., Ali, Abdullah N.A., Kramers, Cees, Härmark, Linda V.D., Burger, David M., Verhoeven, Willem M.A. · 2013 · Journal of Clinical Psychopharmacology
17. Synthesis and Applications of Periodate for Fine Chemicals and Important Pharmaceuticals
    Sebastian Arndt, Philipp J. Kohlpaintner, Kai Oliver Donsbach, Siegfried R. Waldvogel · 2022 · Organic Process Research & Development
18. The effects of varenicline on attention and inhibitory control among treatment-seeking smokers
    Jessica D. Rhodes, Larry W. Hawk, Rebecca L. Ashare, Nicolas J. Schlienz, Martin Christopher Mahoney · 2012 · Psychopharmacology
19. Core Modification of Cytisine: A Modular Synthesis
    Christoph Hirschhäuser, Claire A. Haseler, Timothy C. Gallagher · 2011 · Angewandte Chemie International Edition
20. Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings
    Lara A. Ray, Kelly Elizabeth Courtney, Dara G. Ghahremani, Karen A. Miotto, Arthur L. Brody, Edythe D. London · 2014 · The American Journal of Drug and Alcohol Abuse
21. Pharmacological Intervention of Nicotine Dependence
    Raka Jain, Pradipta Majumder, Tina Gupta · 2013 · BioMed Research International
22. Positive allosteric modulation of α4β2 nicotinic acetylcholine receptors as a new approach to smoking reduction: evidence from a rat model of nicotine self-administration
    Xiu Liu · 2013 · Psychopharmacology
23. Involvement of Proton-Coupled Organic Cation Antiporter in Varenicline Transport at Blood-Brain Barrier of Rats and in Human Brain Capillary Endothelial Cells
    Toshiki Kurosawa, Kei Higuchi, Takashi Okura, Kazumasa Kobayashi, Hiroyuki Kusuhara, Yoshiharu Deguchi · 2017 · Journal of Pharmaceutical Sciences
24. Neurobiological Links Between Nicotine Addiction and Schizophrenia
    Tony Peter George · 2007 · Journal of Dual Diagnosis
25. Localized low‐level re‐expression of high‐affinity mesolimbic nicotinic acetylcholine receptors restores nicotine‐induced locomotion but not place conditioning
    Mineur, Y. S., Brunzell, D. H., Grady, S. R., Lindstrom, J. M., McIntosh, J. M., Marks, M. J., King, S. L., Picciotto, M. R. · 2009 · Genes, Brain and Behavior
26. Disrupting Nicotine Reinforcement
    Jed E. Rose · 2008 · Annals of the New York Academy of Sciences
27. C3-halogenation of cytisine generates potent and efficacious nicotinic receptor agonists
    Juan Andrés Abin‐Carriquiry, Merja H. Voutilainen, Jacques Barik, Bruce K. Cassels, Patricio Iturriaga‐Vásquez, Isabel Bermúdez, Claudia Durand, Federico Dajas, Susan Wonnacott · 2006 · European Journal of Pharmacology
28. Brain Responses to Smoking Cues Differ Based on Nicotine Metabolism Rate
    Mary Falcone, Wen Cao, Leah Bernardo, Rachel Fynvola Tyndale, James Loughead, Caryn E. Lerman · 2015 · Biological Psychiatry
29. Pharmacological treatments for opiate and alcohol addiction: A historical perspective of the last 50 years
    M. Carmen Blanco-Gandía, Marta Rodríguez‐Arias · 2018 · European Journal of Pharmacology
30. Probing Binding Interactions of Cytisine Derivatives to the α4β2 Nicotinic Acetylcholine Receptor
    Annet E. M. Blom, Hugo Rego Campello, Henry A. Lester, Timothy C. Gallagher, Dennis A. Dougherty · 2019 · Journal of the American Chemical Society
31. Effect of the Nicotinic α4β2-receptor Partial Agonist Varenicline on Non-invasive Brain Stimulation-Induced Neuroplasticity in the Human Motor Cortex
    Giorgi Batsikadze, Walter Paulus, Jessica Grundey, Min‐Fang Kuo, Michael Andreas Nitsche · 2014 · Cerebral Cortex
32. Effectiveness of Coadministration of Varenicline, Bupropion, and Serotonin Reuptake Inhibitors in a Smoking Cessation Program in the Real-Life Setting
    Jaqueline Schölz Issa, Tânia Ogawa Abe, Simone Moura, Paulo Caleb Júnior Lima Santos, Alexandre C. Pereira · 2012 · Nicotine & Tobacco Research
33. Neurobiological and Neurophysiological Mechanisms Underlying Nicotine Seeking and Smoking Relapse
    Heath D. Schmidt, Laura E. Rupprecht, Nii Addy · 2018 · Complex Psychiatry
34. Unravelling the mechanism of action of NS9283 , a positive allosteric modulator of ( α 4)3( β 2)2nicotinic ACh receptors
    M. Grupe, Anders A. Jensen, Philip Kiær Ahring, JK Christensen, Morten Grunnet · 2012 · British Journal of Pharmacology
35. La conduite de l’aide au sevrage tabagique
    J. Perriot · 2006 · Revue des Maladies Respiratoires
36. Effect of varenicline on the acute and repeated locomotor responses to nicotine in rats
    Magdalena Zaniewska, Andrew C. McCreary, Roman Stefański, Edmund Przegaliński, Małgorzata Filip · 2008 · Synapse
37. Neuronal nicotinic receptor ligands modulate chronic nicotine-induced ethanol consumption in C57BL/6J mice
    Ravi Kiran Sajja, Shafiqur Rahman · 2012 · Pharmacology Biochemistry and Behavior
38. Structural and Rate Studies of the Formation of Substituted Benzynes
    Jason C. Riggs, Antonio Ramı́rez, Matthew E. Cremeens, Crystal G. Bashore, John Candler, Michael C. Wirtz, Jotham W. Coe, David B. Collum · 2008 · Journal of the American Chemical Society
39. Preclinical Evidence That Activation of Mesolimbic Alpha 6 Subunit Containing Nicotinic Acetylcholine Receptors Supports Nicotine Addiction Phenotype
    Darlene H. Brunzell · 2012 · Nicotine & Tobacco Research
40. Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans
    Mehmet Sofuoglu, Aryeh I. Herman, Marc E. Mooney, Andrew J. Waters · 2009 · Psychopharmacology
41. Nicotinic receptor partial agonists as novel compounds for the treatment of smoking cessation
    Piotr Tutka · 2008 · Expert Opinion on Investigational Drugs
42. Nicotinic acetylcholine receptors containing the α4 subunit are critical for the nicotine-induced reduction of acute voluntary ethanol consumption
    Linzy M. Hendrickson, Paul D Gardner, Andrew R. Tapper · 2011 · Channels
43. Getting cytisine licensed for use world-wide: a call to action
    Natalie K. Walker, Chris Bullen, Joanne Barnes, Hayden J. McRobbie, Piotr Tutka, Martin Raw, Jean‐François Etter, Kamran Siddiqi, Ryan J. Courtney, João Maurício Castaldelli-Maia et al. · 2016 · Addiction
44. Smoking Cessation Efficacy and Safety of Varenicline, an α4β2 Nicotinic Receptor Partial Agonist
    Serena Tonstad · 2006 · The Journal of Cardiovascular Nursing
45. Evaluation of the cardiovascular effects of varenicline in rats
    Engin Burak Selçuk, Meltem Süngü, Hakan Parlakpınar, Necip Ermiş, Elif Taşlıdere, Nigar Vardı, Murat Yalçınsoy, Mustafa Sağır, Alaadin Polat, Mehmet Karataş et al. · 2015 · Drug Design Development and Therapy
46. Thoughts and Acts of Aggression/Violence Toward Others Reported in Association with Varenicline
    Thomas J Moore, Joseph Glenmullen, Curt Daniel Furberg · 2010 · Annals of Pharmacotherapy
47. Gastrointestinal adverse effects of varenicline at maintenance dose: a meta-analysis
    Lawrence K Leung, Francis Patafio, Walter Rosser · 2011 · BMC Clinical Pharmacology
48. α6-Containing nicotinic acetylcholine receptors in midbrain dopamine neurons are poised to govern dopamine-mediated behaviors and synaptic plasticity
    Jennifer N. Berry, Staci E. Engle, J. Michael McIntosh, Ryan M. Drenan · 2015 · Neuroscience
49. Effects of Varenicline on Neural Correlates of Alcohol Salience in Heavy Drinkers
    Vatsalya Vatsalya, Joshua L. Gowin, Melanie L. Schwandt, Reza Momenan, Marion A. Coe, Megan E. Cooke, Daniel W. Hommer, Selena E. Bartlett, Markus A Heilig, Vijay A. Ramchandani · 2015 · The International Journal of Neuropsychopharmacology
50. Varenicline as a treatment for cannabis use disorder: A placebo-controlled pilot trial
    Aimee L. McRae‐Clark, Kevin Michael Gray, Nathaniel L. Baker, Brian J. Sherman, Lindsay M. Squeglia, Gregory L. Sahlem, Amanda M. Wagner, Rachel L. Tomko · 2021 · Drug and Alcohol Dependence
51. The effect of Varenicline and Bupropion on smoking cessation: A network meta-analysis of 20 randomized controlled trials
    Kangle Guo, Shizhong Wang, Xue Shang, E Fenfen, Liangying Hou, Jieyun Li, Yanfei Li, Kehu Yang, Xiuxia Li · 2022 · Addictive Behaviors
52. A Modular Approach to the Asymmetric Synthesis of Cytisine
    Felix R. Struth, Christoph Hirschhäuser · 2016 · European Journal of Organic Chemistry
53. Cholinergic Receptors and Addiction
    Roger L. Papke, Darlene H. Brunzell, Mariella De Biasi · 2020 · Current topics in behavioral neurosciences
54. Total Syntheses of (±)-β-Erythroidine and (±)-8-oxo-β-Erythroidine by an Intramolecular Diels−Alder Cycloaddition of a 2-Amidoacrolein
    Yong He, Raymond L. Funk · 2006 · Organic Letters
55. Divergent Functional Effects of Sazetidine-A and Varenicline During Nicotine Withdrawal
    Turner, Jill R, Wilkinson, Derek S, Poole, Rachel LF, Gould, Thomas J, Carlson, Gregory C, Blendy, Julie A · 2013 · Neuropsychopharmacology
56. The impact of pre-cessation varenicline on behavioral economic indices of smoking reinforcement
    Nicolas J. Schlienz, Larry W. Hawk, Stephen T. Tiffany, Richard J. O’Connor, Martin Christopher Mahoney · 2014 · Addictive Behaviors
57. Activation of α4β2*/α6β2* nicotinic receptors alleviates anxiety during nicotine withdrawal without upregulating nicotinic receptors
    Yohn, Nicole L., Turner, Jill R., Blendy, Julie A. · 2014 · The Journal of Pharmacology and Experimental Therapeutics
58. Smoking cessation therapy with varenicline
    Ganesh Krishna · 2008 · International Journal of COPD
59. Sex differences in COPD management
    Maria Gabriella Matera, Josuel Ora, Luigino Calzetta, Paola Rogliani, Mario Cazzola · 2021 · Expert Review of Clinical Pharmacology
60. Synthesis and Nicotinic Acetylcholine Receptor in Vitro and in Vivo Pharmacological Properties of 2′-Fluoro-3′-(substituted phenyl)deschloroepibatidine Analogues of 2′-Fluoro-3′-(4-nitrophenyl)deschloroepibatidine
    Pauline W. Ondachi, Ana Castro, Charles W. Luetje, Mohamad Imad Damaj, S. Wayne Mascarella, Hernán A. Navarro, Frank Ivy Carroll · 2012 · Journal of Medicinal Chemistry
61. Noribogaine reduces nicotine self-administration in rats
    Qing Chang, Taleen Hanania, Deborah C. Mash, Émeline L. Maillet · 2015 · Journal of Psychopharmacology
62. Patterns of nicotinic receptor antagonism II: Cardiovascular effects in rats
    Emily M. Jutkiewicz, Kenner C. Rice, Frank Ivy Carroll, James Henry Woods · 2013 · Drug and Alcohol Dependence
63. Smoking cessation: present status and future perspectives
    Pasquale Caponnetto, Cristina Russo, Riccardo Polosa · 2012 · Current Opinion in Pharmacology
64. Update on pharmacologic and nonpharmacologic therapies for smoking cessation.
    Jason Schmelzle, Walter Rosser, Richard Birtwhistle · 2008 · Europe PMC (PubMed Central)
65. Counseling Is Effective for Smoking Cessation in Head and Neck Cancer Patients—A Systematic Review and Meta-Analysis
    Ingrid Klemp, Mia C. W. Steffenssen, Vivi Tiphede Bakholdt, Torben Thygesen, Jens Ahm Sørensen · 2016 · Journal of Oral and Maxillofacial Surgery
66. Tobacco and alcohol use during adolescence: Interactive mechanisms in animal models
    Yael Abreu‐Villaça, Alex C. Manhães, Thomas Eichenberg Krahe, Cláudio Carneiro Filgueiras, Anderson Ribeiro‐Carvalho · 2017 · Biochemical Pharmacology
67. Pharmacological approaches to smoking cessation
    Ioanna Mitrouska, Izolde Bouloukaki, Nikolaos M. Siafakas · 2006 · Pulmonary Pharmacology & Therapeutics
68. Neural correlates of attentional bias for smoking cues: modulation by variance in the dopamine transporter gene
    Reagan R. Wetherill, Kanchana Jagannathan, Falk W. Lohoff, Ronald N. Ehrman, Charles P. O’Brien, Anna Rose Childress, Teresa R. Franklin · 2012 · Addiction Biology
69. Combination therapy of varenicline and bupropion in smoking cessation: A meta-analysis of the randomized controlled trials
    Zhaoshuang Zhong, Shijie Zhao, Yan Zhao, Shuyue Xia · 2019 · Comprehensive Psychiatry
70. Evaluation of the effectiveness of cytisine for the treatment of smoking cessation: A systematic review and meta‐analysis
    Omar De Santi, Marcelo Orellana, Cecilia Andrea Di Niro, Vanina Greco · 2023 · Addiction
71. Bacoside A: Role in Cigarette Smoking Induced Changes in Brain
    Ganapathy Vani, K. Anbarasi, Chennam Srinivasulu Shyamaladevi · 2015 · Evidence-based Complementary and Alternative Medicine
72. Synthesis of 1,5-methano-3-benzazocines by intramolecular Buchwald–Hartwig arylation of 2-piperidinones
    Gedu Satyanarayana, Martin Edmund Maier · 2007 · Tetrahedron
73. Orthosteric and Allosteric Ligands of Nicotinic Acetylcholine Receptors for Smoking Cessation
    Tasnim S. Mohamed, Selwyn S. Jayakar, Ayman K. Hamouda · 2015 · Frontiers in Molecular Neuroscience
74. Heterobicyclic Core Retained Hydroarylations through C–H Activation: Synthesis of Epibatidine Analogues
    Deng‐Yuan Li, Zheng-Lu Huang, Pei Nian Liu · 2018 · Organic Letters
75. Chemical Medicine: Novel 10‐Substituted Cytisine Derivatives with Increased Selectivity for α4β2 Nicotinic Acetylcholine Receptors
    Alan P. Kozikowski, Sheela Kochuparambil Chellappan, Yingxian Xiao, Krishna Mohan Bajjuri, Hongbin Yuan, Kenneth J. Kellar, Pavel A. Petukhov · 2007 · ChemMedChem
76. Effects of Chronic Varenicline Treatment on Nicotine, Cocaine, and Concurrent Nicotine+Cocaine Self-Administration
    Nancy K. Mello, Peter A. Fivel, Stephen John Kohut, Frank Ivy Carroll · 2013 · Neuropsychopharmacology
77. Cytisine is neuroprotective in female but not male 6‐hydroxydopamine lesioned parkinsonian mice and acts in combination with 17‐β‐estradiol to inhibit apoptotic endoplasmic reticulum stress in dopaminergic neurons
    Sara M. Zarate, Gauri Pandey, Sunanda Chilukuri, Jose A. Garcia, Brittany Cude, Shannon Storey, Nihal A. Salem, Eric A. Bancroft, Michelle A. Hook, Rahul Srinivasan · 2020 · Journal of Neurochemistry
78. Resisting the Urge to Smoke and Craving during a Smoking Quit Attempt on Varenicline: Results from a Pilot FMRI Study
    Karen J. Hartwell, Todd LeMatty, Aimee L. McRae‐Clark, Kevin Michael Gray, Mark S. George, Kathleen T. Brady · 2013 · The American Journal of Drug and Alcohol Abuse
79. Pharmacologic Characterization of a Nicotine-Discriminative Stimulus in Rhesus Monkeys
    Colin Seamus Cunningham, Martin A. Javors, Lance Richard McMahon · 2012 · Journal of Pharmacology and Experimental Therapeutics
80. Similar activity of mecamylamine stereoisomers in vitro and in vivo
    Roger L. Papke, Clare A. Stokes, Pretal P. Muldoon, Mohamad Imad Damaj · 2013 · European Journal of Pharmacology
81. Conductance of P2X 4 purinergic receptor is determined by conformational equilibrium in the transmembrane region
    Yuichi Minato, Shiho Suzuki, Tomoaki Hara, Yutaka Kofuku, Go Kasuya, Yuichiro Fujiwara, Shunsuke Igarashi, Ei-ichiro Suzuki, Osamu Nureki, Motoyuki Hattori et al. · 2016 · Proceedings of the National Academy of Sciences
82. Use of varenicline in smokeless tobacco cessation influences sleep quality and dream recall frequency but not dream affect
    Francesca Polini, Rosastella Principe, Serena Scarpelli, Francesca Clementi, Luigi De Gennaro · 2016 · Sleep Medicine
83. An RCT with the combination of varenicline and bupropion for smoking cessation: clinical implications for front line use
    Paul M. Cinciripini, Jennifer A. Minnix, Charles E. Green, Jason D. Robinson, Jeffrey M. Engelmann, Francesco Versace, David W. Wetter, Sanjay S. Shete, Maher Karam‐Hage · 2018 · Addiction
84. The role of nicotinic acetylcholine receptors in alcohol-related behaviors
    Carley N. Miller, Helen M. Kamens · 2020 · Brain Research Bulletin
85. An update on therapeutics for tobacco dependence
    Tim Lancaster, Lindsay F Stead, Kate Cahill · 2007 · Expert Opinion on Pharmacotherapy
86. Smoking Cessation
    Rennard, Stephen I., Daughton, David M. · 2014 · Clinics in Chest Medicine
87. The role of varenicline on alcohol-primed self-administration and seeking behavior in rats
    Patrick A. Randall, Anel A. Jaramillo, Suzanne Frisbee, Joyce Besheer · 2015 · Psychopharmacology
88. Pharmacological and molecular studies on the interaction of varenicline with different nicotinic acetylcholine receptor subtypes. Potential mechanism underlying partial agonism at human α4β2 and α3β4 subtypes
    Hugo Rubén Arias, Dominik Feuerbach, Katarzyna M. Targowska‐Duda, Agnieszka Anna Kaczor, Antti Poso, Krzysztof Jóźwiak · 2014 · Biochimica et Biophysica Acta (BBA) - Biomembranes
89. A Review of Varenicline’s Efficacy and Tolerability in Smoking Cessation Studies in Subjects with Schizophrenia
    Mahtab Karkhane Yousefi, Timothy D. Folsom · 2012 · Journal of Addiction Research & Therapy
90. Fluorescence activation mechanism and imaging of drug permeation with new sensors for smoking-cessation ligands
    Aaron L. Nichols, Zack Blumenfeld, Chengcheng Fan, Laura Luebbert, Annet E. M. Blom, Bruce N. Cohen, Jonathan S. Marvin, Philip M. Borden, Charlene H. Kim, Anand K. Muthusamy et al. · 2022 · eLife
91. Dianicline, a Novel 4 2 Nicotinic Acetylcholine Receptor Partial Agonist, for Smoking Cessation: A Randomized Placebo-Controlled Clinical Trial
    Serena Tonstad, Ingar Holme, Philip Tønnesen · 2010 · Nicotine & Tobacco Research
92. Benefits of varenicline vs. bupropion for smoking cessation: a Bayesian analysis of the interaction of reward sensitivity and treatment
    Paul M. Cinciripini, Charles E. Green, Jason D. Robinson, Maher Karam‐Hage, Jeffrey M. Engelmann, Jennifer A. Minnix, David W. Wetter, Francesco Versace · 2017 · Psychopharmacology
93. Contributions of β2 subunit-containing nAChRs to chronic nicotine-induced alterations in cognitive flexibility in mice
    Robert D. Cole, Rachel L. Poole, Dawn M. Guzman, Thomas J. Gould, Vinay Parikh · 2014 · Psychopharmacology
94. Pharmacogenetics factors influencing smoking cessation success; the importance of nicotine metabolism
    Yadira X. Pérez-Páramo, Philip J. Lazarus · 2020 · Expert Opinion on Drug Metabolism & Toxicology
95. Treating Schizophrenia: Novel Targets for the Cholinergic System
    Tammie Money, Elizabeth Scarr, Madhara Udawela, Andrew Stuart Gibbons, Won Je Jeon, M.S. Seo, Brian Dean · 2010 · CNS & Neurological Disorders - Drug Targets
96. Pharmacotherapy for smoking cessation in schizophrenia: a systematic review
    Karolina Kozak, Tony Peter George · 2020 · Expert Opinion on Pharmacotherapy
97. Quantitative Assessment of Exposure–Response Relationships for the Efficacy and Tolerability of Varenicline for Smoking Cessation
    Patanjali Ravva, Marc R. Gastonguay, Jonathan L French, Thomas G. Tensfeldt, Hélène M. Faessel · 2010 · Clinical Pharmacology & Therapeutics
98. The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: Differences in α4β2 nicotinic receptor activation
    Colin Seamus Cunningham, Lance Richard McMahon · 2010 · European Journal of Pharmacology
99. Construction of Bridged Benzazepines via Photo‐Induced Dearomatization
    Ting‐Ting Song, Yong‐Kang Mei, Yan Liu, Xiaoyu Wang, Shiyu Guo, Ding‐Wei Ji, Boshun Wan, Weiming Yuan, Qing‐An Chen · 2023 · Angewandte Chemie International Edition
100. Varenicline and mecamylamine attenuate locomotor sensitization and cross-sensitization induced by nicotine and morphine in mice
     Grażyna Biała, Natasza Staniak · 2010 · Pharmacology Biochemistry and Behavior